Virologica Sinica

, Volume 30, Issue 1, pp 80–81 | Cite as

Experience of the Eliava Institute in bacteriophage therapy

  • Mzia KutateladzeEmail author


Phage Therapy VIROLOGICA SINICA Quality Control Production Resistant Bacterial Strain Phage Preparation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Alavidze Z, Kutateladze M. Bacteriophage therapy. 2001. New York: Academic Press, pp. 89–92.Google Scholar
  2. Kutateladze M, Adamia R. 2008. Medicine et Maladies Infectiouses, 38: 426–430.CrossRefGoogle Scholar
  3. Kutateladze M, Adamia R. 2010. Trends Biotechnol, 28: 591–595.CrossRefPubMedGoogle Scholar
  4. Fitzgerald-Hughes D, Bolkvadze D, Balarjishvili N, et al. 2014. J Antimicrob Chemoth, 69:1148–1150.CrossRefGoogle Scholar
  5. Kutter E, Borysowski J, Miedzybrodzki R, et al. Norfolk: Caister Academic Press, pp. 257–288.Google Scholar

Copyright information

© Wuhan Institute of Virology, CAS and Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.George Eliava Institute of Bacteriophages, Microbiology and VirologyTbilisiGeorgia

Personalised recommendations